145 related articles for article (PubMed ID: 33791882)
1. Applicability of APRI and FIB-4 as a transition indicator of liver fibrosis in patients with chronic viral hepatitis.
Itakura J; Kurosaki M; Setoyama H; Simakami T; Oza N; Korenaga M; Tanaka M; Torimura T; Sakamoto N; Enomoto N; Ueno Y; Kawada N; Kaneko S; Nishiguchi S; Chayama K; Tanaka J; Izumi N; Kanto T
J Gastroenterol; 2021 May; 56(5):470-478. PubMed ID: 33791882
[TBL] [Abstract][Full Text] [Related]
2. Changes in APRI and FIB-4 in HBeAg-negative treatment-naive chronic hepatitis B patients with significant liver histological lesions receiving 5-year entecavir therapy.
Liu R; Guo J; Lu Y; Zhang L; Shen G; Wu S; Chang M; Hu L; Hao H; Li M; Xie Y
Clin Exp Med; 2019 Aug; 19(3):309-320. PubMed ID: 31111345
[TBL] [Abstract][Full Text] [Related]
3. Value of gamma-glutamyltranspeptidase-to-platelet ratio in diagnosis of hepatic fibrosis in patients with chronic hepatitis B.
Hu YC; Liu H; Liu XY; Ma LN; Guan YH; Luo X; Ding XC
World J Gastroenterol; 2017 Nov; 23(41):7425-7432. PubMed ID: 29151696
[TBL] [Abstract][Full Text] [Related]
4. Serum HBV RNA levels predict significant liver fibrosis in patients with chronic HBV infection.
Huang C; Li Q; Xu W; Wang Q; Hu Q; Zhang X; Huang Y; Chen L
Discov Med; 2020; 29(157):119-128. PubMed ID: 33002408
[TBL] [Abstract][Full Text] [Related]
5. Acoustic Radiation Force Impulse Elastography with APRI and FIB-4 to Identify Significant Liver Fibrosis in Chronic Hepatitis B Patients.
Tseng CH; Chang CY; Mo LR; Lin JT; Tai CM; Perng DS; Lin CW; Hsu YC
Ann Hepatol; 2018 Aug; 17(5):789-794. PubMed ID: 30145564
[TBL] [Abstract][Full Text] [Related]
6. Does Incorporating Change in APRI or FIB-4 Indices Over Time Improve the Accuracy of a Single Index for Identifying Liver Fibrosis in Persons With Chronic Hepatitis C Virus Infection?
Gounder PP; Haering C; Bruden DJT; Townshend-Bulson L; Simons BC; Spradling PR; McMahon BJ
J Clin Gastroenterol; 2018 Jan; 52(1):60-66. PubMed ID: 27875352
[TBL] [Abstract][Full Text] [Related]
7. The applicability of non-invasive methods for assessing liver fibrosis in hemodialysis patients with chronic hepatitis C.
Lee JJ; Wei YJ; Lin MY; Niu SW; Hsu PY; Huang JC; Jang TY; Yeh ML; Huang CI; Liang PC; Lin YH; Hsieh MY; Hsieh MH; Chen SC; Dai CY; Lin ZY; Chen SC; Huang JF; Chang JM; Hwang SJ; Huang CF; Chiu YW; Chuang WL; Yu ML
PLoS One; 2020; 15(11):e0242601. PubMed ID: 33216807
[TBL] [Abstract][Full Text] [Related]
8. COMP serum levels: A new non-invasive biomarker of liver fibrosis in patients with chronic viral hepatitis.
Zachou K; Gabeta S; Shums Z; Gatselis NK; Koukoulis GK; Norman GL; Dalekos GN
Eur J Intern Med; 2017 Mar; 38():83-88. PubMed ID: 28100410
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of APRI and FIB-4 for noninvasive assessment of significant fibrosis and cirrhosis in HBeAg-negative CHB patients with ALT ≤ 2 ULN: A retrospective cohort study.
Li Q; Ren X; Lu C; Li W; Huang Y; Chen L
Medicine (Baltimore); 2017 Mar; 96(12):e6336. PubMed ID: 28328813
[TBL] [Abstract][Full Text] [Related]
10. Validation and comparison of simple noninvasive models for the prediction of liver fibrosis in chronic hepatitis C.
Amorim TG; Staub GJ; Lazzarotto C; Silva AP; Manes J; Ferronato Mda G; Shiozawa MB; Narciso-Schiavon JL; Dantas-Correa EB; Schiavon Lde L
Ann Hepatol; 2012; 11(6):855-61. PubMed ID: 23109448
[TBL] [Abstract][Full Text] [Related]
11. Noninvasive serum fibrosis markers for screening and staging chronic hepatitis C virus patients in a large US cohort.
Holmberg SD; Lu M; Rupp LB; Lamerato LE; Moorman AC; Vijayadeva V; Boscarino JA; Henkle EM; Gordon SC;
Clin Infect Dis; 2013 Jul; 57(2):240-6. PubMed ID: 23592832
[TBL] [Abstract][Full Text] [Related]
12. Comparing the efficiency of Fib-4, Egy-score, APRI, and GUCI in liver fibrosis staging in Egyptians with chronic hepatitis C.
Cordie A; Salama A; El-Sharkawy M; El-Nahaas SM; Khairy M; Elsharkawy A; Hassany M; Esmat G
J Med Virol; 2018 Jun; 90(6):1106-1111. PubMed ID: 29476628
[TBL] [Abstract][Full Text] [Related]
13. Impact of age on the diagnostic performances and cut-offs of APRI and FIB-4 for significant fibrosis and cirrhosis in chronic hepatitis B.
Li Q; Lu C; Li W; Huang Y; Chen L
Oncotarget; 2017 Jul; 8(28):45768-45776. PubMed ID: 28514753
[TBL] [Abstract][Full Text] [Related]
14. Progression of Liver Fibrosis in HIV/HCV Co-Infection: A Comparison between Non-Invasive Assessment Methods and Liver Biopsy.
Schmid P; Bregenzer A; Huber M; Rauch A; Jochum W; Müllhaupt B; Vernazza P; Opravil M; Weber R;
PLoS One; 2015; 10(9):e0138838. PubMed ID: 26418061
[TBL] [Abstract][Full Text] [Related]
15. Stepwise application of fibrosis index based on four factors, red cell distribution width-platelet ratio, and aspartate aminotransferase-platelet ratio for compensated hepatitis B fibrosis detection.
Chen YP; Hu XM; Liang XE; Huang LW; Zhu YF; Hou JL
J Gastroenterol Hepatol; 2018 Jan; 33(1):256-263. PubMed ID: 28452125
[TBL] [Abstract][Full Text] [Related]
16. A new combined predicting model using a non-invasive score for the assessment of liver fibrosis in patients presenting with chronic hepatitis B virus infection.
Ben Ayed H; Koubaa M; Yaich S; Rekik K; Ben Jemaa T; Maaloul I; Marrekchi C; Damak J; Ben Jemaa M
Med Mal Infect; 2019 Nov; 49(8):607-615. PubMed ID: 30871816
[TBL] [Abstract][Full Text] [Related]
17. Validation of a machine learning approach using FIB-4 and APRI scores assessed by the metavir scoring system: A cohort study.
Hashem A; Awad A; Shousha H; Alakel W; Salama A; Awad T; Mabrouk M
Arab J Gastroenterol; 2021 Jun; 22(2):88-92. PubMed ID: 33985905
[TBL] [Abstract][Full Text] [Related]
18. Validation of APRI and FIB-4 score in an Antwerp cohort of chronic hepatitis C patients.
Verlinden W; Bourgeois S; De Maeyer M; Vonghia L; Vanwolleghem T; Michielsen P; Francque S
Acta Gastroenterol Belg; 2015 Dec; 78(4):373-80. PubMed ID: 26712046
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic accuracy of APRI and FIB-4 for predicting hepatitis B virus-related liver fibrosis accompanied with hepatocellular carcinoma.
Xiao G; Zhu F; Wang M; Zhang H; Ye D; Yang J; Jiang L; Liu C; Yan L; Qin R
Dig Liver Dis; 2016 Oct; 48(10):1220-6. PubMed ID: 27599803
[TBL] [Abstract][Full Text] [Related]
20. Fibrosis index based on four factors better predicts advanced fibrosis or cirrhosis than aspartate aminotransferase/platelet ratio index in chronic hepatitis C patients.
Wang CC; Liu CH; Lin CL; Wang PC; Tseng TC; Lin HH; Kao JH
J Formos Med Assoc; 2015 Oct; 114(10):923-8. PubMed ID: 26279173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
